Substance abuse and schizophrenia

Impediments to optimal care

Ihsan M Salloum, Howard B. Salloum, Dennis C. Salloum

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

ABSTRACT With lifetime prevalence estimates of substance abuse among schizophrenics as high as 47.01 % there is an increasing awareness of the importance of this dual diagnosis and the global deficiencies in our knowledge about this comorbid condition. Patients with substance abuse disorders and schizophrenia are problematic from a clinical, economic, and health care systems perspective. The lack of systematic research into phenomenology, etiology, and treatment approaches (both psychotherapeutic and psychopharmacologic) has hindered the development of an adequate strategy to care for the needs of these patients. Thus, these patients place a significant burden on the mental health delivery system through chronic disability, social dysfunction, frequent rehospitalizations, and poor overall treatment compliance. The authors critically review the contemporary literature relevant to concurrent substance abuse and schizophrenia, highlight major deficiencies in our knowledge, and call for research to reduce the individual, economic, and social costs of this condition.

Original languageEnglish
Pages (from-to)321-336
Number of pages16
JournalAmerican Journal of Drug and Alcohol Abuse
Volume17
Issue number3
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Substance-Related Disorders
Schizophrenia
Economics
Dual (Psychiatry) Diagnosis
Social Conditions
Research
Patient Care
Mental Health
Delivery of Health Care
Costs and Cost Analysis
Therapeutics

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Clinical Psychology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Substance abuse and schizophrenia : Impediments to optimal care. / Salloum, Ihsan M; Salloum, Howard B.; Salloum, Dennis C.

In: American Journal of Drug and Alcohol Abuse, Vol. 17, No. 3, 01.01.1991, p. 321-336.

Research output: Contribution to journalArticle

Salloum, Ihsan M ; Salloum, Howard B. ; Salloum, Dennis C. / Substance abuse and schizophrenia : Impediments to optimal care. In: American Journal of Drug and Alcohol Abuse. 1991 ; Vol. 17, No. 3. pp. 321-336.
@article{e355fde0cdfa4e9ebd3c20ccf74f197c,
title = "Substance abuse and schizophrenia: Impediments to optimal care",
abstract = "ABSTRACT With lifetime prevalence estimates of substance abuse among schizophrenics as high as 47.01 {\%} there is an increasing awareness of the importance of this dual diagnosis and the global deficiencies in our knowledge about this comorbid condition. Patients with substance abuse disorders and schizophrenia are problematic from a clinical, economic, and health care systems perspective. The lack of systematic research into phenomenology, etiology, and treatment approaches (both psychotherapeutic and psychopharmacologic) has hindered the development of an adequate strategy to care for the needs of these patients. Thus, these patients place a significant burden on the mental health delivery system through chronic disability, social dysfunction, frequent rehospitalizations, and poor overall treatment compliance. The authors critically review the contemporary literature relevant to concurrent substance abuse and schizophrenia, highlight major deficiencies in our knowledge, and call for research to reduce the individual, economic, and social costs of this condition.",
author = "Salloum, {Ihsan M} and Salloum, {Howard B.} and Salloum, {Dennis C.}",
year = "1991",
month = "1",
day = "1",
doi = "10.3109/00952999109027556",
language = "English",
volume = "17",
pages = "321--336",
journal = "American Journal of Drug and Alcohol Abuse",
issn = "0095-2990",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Substance abuse and schizophrenia

T2 - Impediments to optimal care

AU - Salloum, Ihsan M

AU - Salloum, Howard B.

AU - Salloum, Dennis C.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - ABSTRACT With lifetime prevalence estimates of substance abuse among schizophrenics as high as 47.01 % there is an increasing awareness of the importance of this dual diagnosis and the global deficiencies in our knowledge about this comorbid condition. Patients with substance abuse disorders and schizophrenia are problematic from a clinical, economic, and health care systems perspective. The lack of systematic research into phenomenology, etiology, and treatment approaches (both psychotherapeutic and psychopharmacologic) has hindered the development of an adequate strategy to care for the needs of these patients. Thus, these patients place a significant burden on the mental health delivery system through chronic disability, social dysfunction, frequent rehospitalizations, and poor overall treatment compliance. The authors critically review the contemporary literature relevant to concurrent substance abuse and schizophrenia, highlight major deficiencies in our knowledge, and call for research to reduce the individual, economic, and social costs of this condition.

AB - ABSTRACT With lifetime prevalence estimates of substance abuse among schizophrenics as high as 47.01 % there is an increasing awareness of the importance of this dual diagnosis and the global deficiencies in our knowledge about this comorbid condition. Patients with substance abuse disorders and schizophrenia are problematic from a clinical, economic, and health care systems perspective. The lack of systematic research into phenomenology, etiology, and treatment approaches (both psychotherapeutic and psychopharmacologic) has hindered the development of an adequate strategy to care for the needs of these patients. Thus, these patients place a significant burden on the mental health delivery system through chronic disability, social dysfunction, frequent rehospitalizations, and poor overall treatment compliance. The authors critically review the contemporary literature relevant to concurrent substance abuse and schizophrenia, highlight major deficiencies in our knowledge, and call for research to reduce the individual, economic, and social costs of this condition.

UR - http://www.scopus.com/inward/record.url?scp=0025887080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025887080&partnerID=8YFLogxK

U2 - 10.3109/00952999109027556

DO - 10.3109/00952999109027556

M3 - Article

VL - 17

SP - 321

EP - 336

JO - American Journal of Drug and Alcohol Abuse

JF - American Journal of Drug and Alcohol Abuse

SN - 0095-2990

IS - 3

ER -